The best i can see is that Remdesivir got an EUA based on a P3 trial that had 200 patients. Expecting an EUA on a 75 patient P2 trial only is optimistic, i guess. It does show that the primary readout with 195 patients in our P3 S/C trial does bring us up to the level of what Remdesivir got their EUA.